Thomas Lavoie

3.7k total citations · 1 hit paper
39 papers, 2.9k citations indexed

About

Thomas Lavoie is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Thomas Lavoie has authored 39 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Thomas Lavoie's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Protein Structure and Dynamics (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Thomas Lavoie is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Protein Structure and Dynamics (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Thomas Lavoie collaborates with scholars based in United States, Australia and Germany. Thomas Lavoie's co-authors include Sandra J. Smith‐Gill, Christopher C. Goodnow, Ronald J. Trent, H. Pritchard-Briscoe, Robert Brink, Stephen Adelstein, J. Crosbie, Robert H. Loblay, Antony Basten and John S. Wotherspoon and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Thomas Lavoie

37 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice

1988 1.3k citations Thomas Lavoie, Sandra J. Smith‐Gill et al. profile →

Peers

Countries citing papers authored by Thomas Lavoie

Since Specialization

Citations

This map shows the geographic impact of Thomas Lavoie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lavoie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lavoie more than expected).

Fields of papers citing papers by Thomas Lavoie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lavoie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lavoie. The network helps show where Thomas Lavoie may publish in the future.

Co-authorship network of co-authors of Thomas Lavoie

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lavoie. A scholar is included among the top collaborators of Thomas Lavoie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lavoie. Thomas Lavoie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of Meropenem Stability in Meropenem Admixtures Using 2 g Vials and Normal Saline Prepared Using addEASE ^® Connectors 2025 ·Hospital Pharmacy ·Christian M Gill, Teresa Sierra, (unknown), (unknown), Thomas Lavoie, Brahim Achour	0
2	Association between nirmatrelvir/ritonavir treatment and antibiotic prescribing in the outpatient setting among patients with COVID-19 2025 ·Microbiology Spectrum ·Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, Thomas Lavoie, Laura Puzniak, Evan J Zasowski, Luis Jódar, (unknown), Kerry L. LaPlante, John M. McLaughlin	1
3	Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1 2023 ·Journal of Interferon & Cytokine Research ·Nicole A. de Weerd, (unknown), (unknown), Antony Y. Matthews, (unknown), J.P. Vivian, San Sui Lim, D. Lorne Tyrrell, (unknown), (unknown), Harold Dickensheets, Thomas Lavoie, Raymond P. Donnelly, Paul J. Hertzog, Deanna M. Santer	5
4	Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention 2023 ·Clinical Infectious Diseases ·Thomas Lavoie, Haley J. Appaneal, Kerry L. LaPlante	7
5	High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a 2014 ·Protein Expression and Purification ·(unknown), Tara M. Stauffer, Surinder M. Singh, Thomas Lavoie, Krishna M.G. Mallela	22
6	PS3-01 Multiplex profiling of cytokines released by A549 human lung epithelial cells after infection with encephalomyocarditis virus and vesicular stomatitis virus 2010 ·Cytokine ·(unknown), Christina Caruso, (unknown), Ronald Jubin, William A. Clark, Thomas Lavoie, Sidney Pestka	1
7	Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Richard Sulsky, David R. Magnin, Yanting Huang, Ligaya M. Simpkins, Prakash C. Taunk, Manorama M. Patel, Yeheng Zhu, Terry R. Stouch, Donna Bassolino‐Klimas, Rex A. Parker, Thomas Harrity, Robert H. Stoffel, David S. Taylor, Thomas Lavoie, Kevin Kish, Bruce L. Jacobson, S. Sheriff, Leonard P. Adam, William R. Ewing, Jeffrey A. Robl	126
8	Characterization of the Three-Dimensional Solution Structure of Human Profilin: 1H, 13C, and 15N NMR Assignments amd Global Folding Pattern 2001 ·Europe PMC (PubMed Central) ·William J. Metzler, Keith L. Constantine, Mark S. Friedrichs, Aneka Bell, Eileen Ernst, Thomas Lavoie, Luciano Mueller	74
9	Crystallization and preliminary X-ray analysis of CTLA-4 (CD152) membrane-external domain 2000 ·Acta Crystallographica Section D Biological Crystallography ·ChiehYing Y. Chang, (unknown), Thomas Lavoie, Robert Peach, Howard Einspahr, S. Sheriff	3
10	Structural differences among monoclonal antibodies with distinct fine specificities and kinetic properties 1999 ·Molecular Immunology ·Thomas Lavoie, Surender Mohan, Claudia A. Lipschultz, Jean‐Charles Grivel, (unknown), C R Mainhart, Lauren Kam-Morgan, William N. Drohan, Sandra J. Smith‐Gill	26
11	Polyproline binding is an essential function of human profilin in yeast 1999 ·European Journal of Biochemistry ·Darin Ostrander, Eileen Ernst, Thomas Lavoie, Jessica A. Gorman	30
12	Normal Intrauterine Pregnancy Is Unlikely in Emergency Department Patients with Either Menstrual Days >38 Days or β‐hCG >3,000 mlU/mL, but without a Gestational Sac on Ultrasonography 1997 ·Academic Emergency Medicine ·Robert Dart, Beth Kaplan, Luis Ortiz, John P. Cloherty, Thomas Lavoie	15
13	Characterization of a new four‐chain coiled‐coil: Influence of chain length on stability 1995 ·Protein Science ·Robert Fairman, (unknown), Luciano Mueller, Thomas Lavoie, (unknown), Jiří Novotný, Gary R. Matsueda	82
14	Refined solution structure of human profilin I 1995 ·Protein Science ·William J. Metzler, Bennett T. Farmer, Keith L. Constantine, Mark S. Friedrichs, Luciano Mueller, Thomas Lavoie	35
15	A Simple Method for Methionyl ϵ-Methyl 1H and 13C Chemical-Shift Identification in 13C-Labeled Proteins 1995 ·Journal of Magnetic Resonance Series B ·B.T Farmer, Thomas Lavoie, Luciano Mueller, William J. Metzler	1
16	Relaxation study of the backbone dynamics of human profilin by two‐dimensional ¹H‐¹⁵N NMR 1993 ·FEBS Letters ·Keith L. Constantine, Mark S. Friedrichs, Aneka Bell, Thomas Lavoie, Luciano Mueller, William J. Metzler	4
17	Characterization of the three-dimensional solution structure of human profilin: proton, carbon-13, and nitrogen-15 NMR assignments and global folding pattern 1993 ·Biochemistry ·William J. Metzler, Keith L. Constantine, Mark S. Friedrichs, Aneka Bell, Eileen Ernst, Thomas Lavoie, Luciano Mueller	113
18	[36] Site-directed mutagenesis in analysis of protein-protein interactions 1993 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Lauren Kam-Morgan, Thomas Lavoie, Sandra J. Smith‐Gill, Jack F. Kirsch	7
19	Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme 1992 ·The Journal of Immunology ·Thomas Lavoie, William N. Drohan, Sandra J. Smith‐Gill	128
20	A three-dimensional model of an anti-lysozyme antibody 1987 ·Journal of Molecular Biology ·Sandra J. Smith‐Gill, C R Mainhart, Thomas Lavoie, Richard J. Feldmann, William N. Drohan, Bernard R. Brooks	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact